<h3>Purpose/Objective(s)</h3> MR Linac (MRL) has the advantage of using high soft tissue contrast imaging to track the changes in target and critical organs on a daily basis during the entire radiation treatment course. The potential benefits include improved local control and decreased risk of toxicities. We present our experience on using the adapt-to-shape (ATS) technique on a 1.5 MR-Linac for optimized adaptive treatment of our head and neck (HN) patients. <h3>Materials/Methods</h3> Twelve HN patients were treated on a 1.5 MR-Linac in 2021 with one or more adapt-to-shape (ATS) treatment plans. All patients also had backup plans on another Linac unit. We compared the treatment planning software reference plans and backup TPS plans. Adapt-to-position (ATP) plan was routinely used for treatments, while ATS plan was generated based on physician's request, on the observation of daily anatomy change, or on the challenges of ATP plans to meet clinical goals. For patients with ATS plans, CTV volumes and dosimetric criteria of the daily treatments were recorded. ATS plans were compared to ATP plans and the original reference plan. <h3>Results</h3> 12 HN patients were treated in the oropharynx area (n=9), larynx area (n=2), and nasopharynx area (n=1). Median prescription was 69.96Gy (range: 63Gy – 69.96Gy) in 33 fractions (range: 28-33 fractions). MRL reference plans achieved all clinical goals but with lower primary CTV coverage, higher heterogeneity, and higher brainstem and spinal cord maximum dose (p<0.05) when compared to backup plans. 95.5% of the total 351 treatments were performed on the MRL, while 4.5% were performed using the backup plan. A total of 32 ATS plans (15 online, 17 offline) were generated for all 12 patients, and the median number of ATS plans per patient was 2 (range: 1 to 5). Comparing to the original reference plans, the volume change of the primary CTV in ATS plans was -10.2% ± 14.7% (range: -34.1% to 9.1%) in the first half of the treatment course, and -28.1% ± 21.7% (range: -53.1% to -1.6%) in the second half of the treatment course. The daily dose to nearby critical organs was observed to reduce up to 31% after CTV volume shrank. For 8 of the 12 patients, ATP plans struggled to meet the clinical goals of one or more critical organs (brainstem, brachial plexus, optic nerve, parotid) on some treatment days, and ATS plans followed thereafter to verify the contours and adjust optimization objectives to improve the plans. The ATS plans were used as new reference plans for later treatments. With the help of ATS planning, the observed dosimetric values of challenging organs were well below tolerance. <h3>Conclusion</h3> Close monitoring of target and critical organs have the potential to improve local control and reduce toxicities. ATS planning on the MR-Linac system played an important role in optimizing radiation treatment for HN cancer.
Read full abstract